SCOPUS 정보 검색 플랫폼

Critical Care Medicine

Volumn 43, Issue 6, 2015, Pages 1346-1347

Time for Tailored Antimicrobials: Adapted Bacteriophages in the ICU

(1) Witzenrath, Martin a

a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN (Germany)

Author keywords

antimicrobial resistance; bacteriophage; hospital acquired pneumonia; ventilator associated pneumonia

Indexed keywords

ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BACTERIOPHAGE; BACTERIUM ISOLATION; CANDIDA ALBICANS; COMMENSAL; EDITORIAL; HEALTH CARE COST; HOSPITAL ACQUIRED PNEUMONIA; HUMAN; INFECTION RATE; INNATE IMMUNITY; INTENSIVE CARE UNIT; MORTALITY; PEPTOCLOSTRIDIUM DIFFICILE; PRIORITY JOURNAL; ANIMAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; MALE; PNEUMONIA, BACTERIAL; PNEUMONIA, VENTILATOR-ASSOCIATED; VIROLOGY;

ANIMALS; BACTERIOPHAGES; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; MALE; PNEUMONIA, BACTERIAL; PNEUMONIA, VENTILATOR-ASSOCIATED;

EID: 84937551186 PISSN: 00903493 EISSN: 15300293 Source Type: Journal
DOI: 10.1097/CCM.0000000000001038 Document Type: Editorial

Times cited : (2)

References (9)

1
- 84937584187
- Accessed on February 18, 2015
- Available at: http://www.cdc.gov/drugresistance/pdf/ar-threats-2013-508.pdf. Accessed on February 18, 2015

2
- 83655193474
- Adapting to environmental stresses: The role of the microbiota in controlling innate immunity and behavioral responses
- Fagundes CT, Amaral FA, Teixeira AL, et al: Adapting to environmental stresses: The role of the microbiota in controlling innate immunity and behavioral responses. Immunol Rev 2012; 245:250-264
- (2012) Immunol Rev , vol.245 , pp. 250-264
- Fagundes, C.T.¹ Amaral, F.A.² Teixeira, A.L.³

3
- 80052695183
- Phage treatment of human infections
- Abedon ST, Kuhl SJ, Blasdel BG, et al: Phage treatment of human infections. Bacteriophage 2011; 1:66-85
- (2011) Bacteriophage , vol.1 , pp. 66-85
- Abedon, S.T.¹ Kuhl, S.J.² Blasdel, B.G.³

4
- 84899733264
- Perspective: The age of the phage
- Matsuzaki S, Uchiyama J, Takemura-Uchiyama I, et al: Perspective: The age of the phage. Nature 2014; 509:S9
- (2014) Nature , vol.509 , pp. S9
- Matsuzaki, S.¹ Uchiyama, J.² Takemura-Uchiyama, I.³

5
- 84891713097
- A historical overview of bacteriophage therapy as an alternative to antibiotics for the treatment of bacterial pathogens
- Wittebole X, De Roock S, Opal SM: A historical overview of bacteriophage therapy as an alternative to antibiotics for the treatment of bacterial pathogens. Virulence 2014; 5:226-235
- (2014) Virulence , vol.5 , pp. 226-235
- Wittebole, X.¹ De Roock, S.² Opal, S.M.³

6
- 80052601908
- Pros and cons of phage therapy
- Loc-Carrillo C, Abedon ST: Pros and cons of phage therapy. Bacteriophage 2011; 1:111-114
- (2011) Bacteriophage , vol.1 , pp. 111-114
- Loc-Carrillo, C.¹ Abedon, S.T.²

7
- 84937556720
- Treatment of Highly Virulent Extraintestinal Pathogenic Escherichia coli Pneumonia with Bacteriophages
- Dufour N, Debarbieux L, Fromentin M, et al: Treatment of Highly Virulent Extraintestinal Pathogenic Escherichia coli Pneumonia With Bacteriophages. Crit Care Med 2015; 43:e190-e198
- (2015) Crit Care Med , vol.43 , pp. e190-e198
- Dufour, N.¹ Debarbieux, L.² Fromentin, M.³

8
- 84901405086
- Mechanical ventilation drives pneumococcal pneumonia into lung injury and sepsis in mice: Protection by adrenomedullin
- Müller-Redetzky HC, Will D, Hellwig K, et al: Mechanical ventilation drives pneumococcal pneumonia into lung injury and sepsis in mice: Protection by adrenomedullin. Crit Care 2014; 18:R73
- (2014) Crit Care , vol.18 , pp. R73
- Müller-Redetzky, H.C.¹ Will, D.² Hellwig, K.³

9
- 64349102620
- Systemic use of the endolysin Cpl-1 rescues mice with fatal pneumococcal pneumonia
- Witzenrath M, Schmeck B, Doehn JM, et al: Systemic use of the endolysin Cpl-1 rescues mice with fatal pneumococcal pneumonia. Crit Care Med 2009; 37:642-649
- (2009) Crit Care Med , vol.37 , pp. 642-649
- Witzenrath, M.¹ Schmeck, B.² Doehn, J.M.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.